ENCOMPASS HEALTH CORP (EHC)

US29261A1007 - Common Stock

83.21  -0.21 (-0.25%)

After market: 83.21 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
4.015B
12.58%		4.349B
8.31%		4.801B
10.41%		5.313B
10.66%
EBITDA
YoY % growth
916M
18.44%		873.8M
-4.61%		1.006B
15.09%		1.054B
4.80%
EBIT
YoY % growth
659.4M
24.32%		630.2M
-4.43%		731.8M
16.12%		791.96M
8.22%
Operating Margin
16.42%14.49%15.24%14.91%
EPS
YoY % growth
4.22
46.02%		3.41
-19.19%		3.64
6.74%		4.00
10.01%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		1.03
8.06%
Revenue
Q2Q % growth		1.311B
10.44%
EBITDA
Q2Q % growth		267.41M
EBIT
Q2Q % growth		203.47M
10.64%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 1.12
27.27%		0.950.1718.50%
Q4 2023
Q2Q % growth		 0.95
7.95%		0.820.1315.27%
Q3 2023
Q2Q % growth		 0.86
28.36%		0.780.0810.73%
Q2 2023
Q2Q % growth		 0.95
6.74%		0.750.2026.24%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 1.247B
9.63%		1.249B-2.2M-0.18%
Q3 2023
Q2Q % growth		 1.207B
10.78%		1.206B900K0.07%
Q2 2023
Q2Q % growth		 1.187B
11.73%		1.172B15.1M1.29%
Q1 2023
Q2Q % growth		 1.16B
9.54%		1.156B4.4M0.38%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.72% 3.09% -0.09% 3.19%
Revenue0% 1.26% 0.08% 1.28%